<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27(9)</volume><submitter>Yamazaki T</submitter><pubmed_abstract>Detecting antibodies, particularly those targeting donor human leukocyte antigens in organ transplantation and self-antigens in autoimmune diseases, is crucial for diagnosis and therapy. Radioprotective 105 (RP105), a Toll-like receptor family protein, is expressed in immune-competent cells, such as B cells. Studies in mice have shown that the anti-mouse RP105 antibody strongly activates B cells and triggers an adjuvant effect against viral infections. However, the anti-human RP105 antibody (ɑhRP105) weakly activates human B cells. This study established new culture conditions under, which human B cells are strongly activated by the ɑhRP105. When combined with CpGDNA, specific antibody production against blood group carbohydrates, ɑGal, and SARS-CoV-2 was successfully detected in human B c</pubmed_abstract><journal>iScience</journal><pagination>110649</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11380396</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Human RP105 monoclonal antibody enhances antigen-specific antibody production in unique culture conditions.</pubmed_title><pmcid>PMC11380396</pmcid><pubmed_authors>Imai M</pubmed_authors><pubmed_authors>Okada M</pubmed_authors><pubmed_authors>Kobayashi T</pubmed_authors><pubmed_authors>Ishiyama K</pubmed_authors><pubmed_authors>Shizuku M</pubmed_authors><pubmed_authors>Akashi-Takamura S</pubmed_authors><pubmed_authors>Okuzaki D</pubmed_authors><pubmed_authors>Inui M</pubmed_authors><pubmed_authors>Tomono S</pubmed_authors><pubmed_authors>Iwasaki K</pubmed_authors><pubmed_authors>Miwa Y</pubmed_authors><pubmed_authors>Yamazaki T</pubmed_authors><pubmed_authors>Ashimine S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Human RP105 monoclonal antibody enhances antigen-specific antibody production in unique culture conditions.</name><description>Detecting antibodies, particularly those targeting donor human leukocyte antigens in organ transplantation and self-antigens in autoimmune diseases, is crucial for diagnosis and therapy. Radioprotective 105 (RP105), a Toll-like receptor family protein, is expressed in immune-competent cells, such as B cells. Studies in mice have shown that the anti-mouse RP105 antibody strongly activates B cells and triggers an adjuvant effect against viral infections. However, the anti-human RP105 antibody (ɑhRP105) weakly activates human B cells. This study established new culture conditions under, which human B cells are strongly activated by the ɑhRP105. When combined with CpGDNA, specific antibody production against blood group carbohydrates, ɑGal, and SARS-CoV-2 was successfully detected in human B c</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2026-06-02T22:58:58.436Z</modification><creation>2025-04-04T00:26:20.716Z</creation></dates><accession>S-EPMC11380396</accession><cross_references><pubmed>39246445</pubmed><doi>10.1016/j.isci.2024.110649</doi></cross_references></HashMap>